TLR3 and neoplasm: Moreover, NK cells were also involved in the reshaping of the tumor microenvironment into one responsive to ICB through sensitization therapy consisting of IFNγ, anti-IL-10 and TLR3 agonist poly-IC in subcutaneous tumor models.21